跳至主要内容
临床试验/ISRCTN85866583
ISRCTN85866583已完成未知

Early diagnosis of invasive aspergillosis in a high risk group of patients using serum and bronchoalveolar lavage fluid, real time polymerase chain reaction (PCR) and galactomannan enzyme-linked immunosorbent assay (ELISA)

Barts and The London NHS Trust (UK)0 个研究点目标入组 300 人开始时间: 2010年5月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Informed consent
  • 2. Patients with acute myeloid leukemia (AML), myelodysplastic syndromes (MDS) and acute lymphoblastic leukemia (ALL) undergoing intensive chemotherapy (predicted neutropenia of less than 0.5 x 10^9/L for greater than 10 days) and/or receiving high dose steroids
  • 3. Patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT)
  • 4. Patients requiring high dose steroids for graft versus host disease post HSCT
  • 5. Patients with a history of probable or proven invasive aspergillosis and having chemotherapy, regardless of their underlying haematological malignancy
  • 6. Aged greater than 18 years, either sex

排除标准

  • 1. Inability to give informed consent
  • 2. Patients aged less than 18 years
  • 3. Pre-existing chest disease

研究者

发起方
Barts and The London NHS Trust (UK)

相似试验